Progress in Refining the Clinical Management of Cancer of Unknown Primary in the Molecular Era

Nature Reviews Clinical Oncology
03 Jun, 2020 ,

Elie Rassy conducted a study to assess the Cancer of unknown primary is an enigmatic disease entity encompassing heterogeneous malignancies without a detectable primary tumour as it is the need of the hour to know the clinical management of Cancer of unknown primary in the era of precision medicine. The published data reveal that the accuracy of site-of-origin predictions made using Cancer of unknown primary classifiers ranges between 54% and 98% when compared with the assignment made according to the recommended clinicopathological criteria.